NIST bill boosts manufacturer partnership funding
This article was originally published in The Tan Sheet
Executive SummaryThe National Institute of Standards and Technology Authorization Act of 2010 calls for increased annual appropriations for NIST's Manufacturing Extension Partnership Program, which helps small- and medium-sized manufacturers compete. H.R. 5074, introduced April 20, would authorize $141.1 million for MEP in fiscal 2011 and up to $184.9 million in fiscal 2015. Bill sponsor Rep. David Wu, D-Ore., whose subcommittee favorably reported the legislation to the full House Science and Technology Committee, said an innovative services initiative in the bill "will help small manufacturing improve energy efficiency, use new technologies and generate high-tech products.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.